News

The NASDAQ 100 Pre-Market Indicator is down -314.44 to 21,113.5. The total Pre-Market volume is currently 181,751,637 shares traded.

The following are the most active stocks for the pre-market session:

Direxion Daily TSLA Bull 2X Shares (TSLL) is -1.18 at $14.24, with 26,180,383 shares traded. This represents a 126.39% increase from its 52 Week Low.

ProShares UltraPro Short QQQ (SQQQ) is +1.08 at $24.46, with 12,027,307 shares traded. This represents a 4.98% increase from its 52 Week Low.

NVIDIA Corporation (NVDA) is -3.77 at $131.63, with 9,091,650 shares traded. As reported by Zacks, the current mean recommendation for NVDA is in the "buy range".

ProShares UltraPro QQQ (TQQQ) is -3.2501 at $68.20, with 5,569,131 shares traded. This represents a 94.86% increase from its 52 Week Low.

Novavax, Inc. (NVAX) is +1.34 at $8.07, with 5,395,902 shares traded. NVAX's current last sale is 44.83% of the target price of $18.

Tesla, Inc. (TSLA) is -13.58 at $336.40, with 4,386,270 shares traded. TSLA's current last sale is 112.13% of the target price of $300.

D-Wave Quantum Inc. (QBTS) is +0.22 at $12.47, with 3,458,207 shares traded. As reported by Zacks, the current mean recommendation for QBTS is in the "buy range".

UnitedHealth Group Incorporated (UNH) is +12.09 at $304.00, with 2,993,379 shares traded. As reported by Zacks, the current mean recommendation for UNH is in the "buy range".

Johnson & Johnson (JNJ) is +0.33 at $151.66, with 1,693,626 shares traded. JNJ's current last sale is 89.74% of the target price of $169.

Kenvue Inc. (KVUE) is +0.02 at $24.20, with 1,475,388 shares traded. Over the last four weeks they have had 3 up revisions for the earnings forecast, for the fiscal quarter ending Mar 2026. The consensus EPS forecast is $0.28. KVUE's current last sale is 100.83% of the target price of $24.

BigBear.ai, Inc. (BBAI) is -0.1699 at $3.50, with 1,134,210 shares traded. BBAI's current last sale is 70% of the target price of $5.

IonQ, Inc. (IONQ) is -1.6804 at $33.31, with 953,065 shares traded. As reported by Zacks, the current mean recommendation for IONQ is in the "buy range".

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.